EXPO
$66.76+1.61 (+2.47%)
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally.
Recent News
How The Exponent (EXPO) Story Is Shifting As Analysts Reframe Its Premium Valuation
Exponent’s updated analyst model now points to a fair value of about US$91.67, up from US$85.50, a mid single digit move that puts more focus on how the current share price lines up with this refreshed target. Bullish and cautious voices alike are using this shift to reassess how earnings quality, project execution, and the company’s premium valuation interact over time. As you read on, you will see how to follow this evolving narrative and what it might mean for your own view on...
Zacks Industry Outlook Highlights Stantec, FTI Consulting and Exponent
Stantec and peers gain from booming consulting demand, as digital transformation and resilient economic activity drive steady growth across the industry.
3 Stocks to Consider From the Prospering Consulting Services Industry
The Zacks Consulting Services industry is poised to prosper, with service activities remaining healthy. STN, FCN and EXPO are three stocks well-positioned to capitalize on demand strength.
3 Reasons to Avoid EXPO and 1 Stock to Buy Instead
Since September 2025, Exponent has been in a holding pattern, posting a small loss of 1% while floating around $70.25.
3 Small-Cap Stocks We Find Risky
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.